Colorectal cancer (CRC) is one of the most common cancers globally with considerable geographic variation ([@bib2]; [@bib8]). Environmental factors such as physical inactivity, body and abdominal fatness, red and processed meat and excess alcohol consumption may contribute to CRC incidence ([@bib36]; [@bib10]; [@bib28]; [@bib34]; [@bib1]). Some researchers speculate that the recent high CRC rates in Japan and Korea may be explained by a genetic predisposition, even when consuming a similar diet, caused by Asian\'s higher sensitivity and susceptibility to gastric and colon cancer ([@bib20]; [@bib17]).

The increasing trend of CRC in Japan might also be attributed to the common lifestyle, including the consumption of cereals such as rice, which Japanese living overseas presumably continue to consume. Rice is a staple food in Japan, typically consumed in the form of white rice ([@bib15]; [@bib25]; [@bib27]; [@bib31]). There is also some, albeit limited, evidence from the 1970s suggesting large quantities of rice may increase the risk of CRC ([@bib4]; [@bib10]). However, the evidence for rice and CRC risk in the general population has been sparse. Therefore, we for the first time analysed a large-scale prospective population-based cohort to understand the association between CRC and rice intake in the Japanese population.

Materials and methods
=====================

Study population
----------------

The Japan Public Health Center-based prospective Study (JPHC Study) is a 30-year on-going cohort study focusing on cancer, cardiovascular and other lifestyle-related diseases, consisting of ∼140 000 Japanese citizens, aged 40--69 years at baseline (1990--1994), in 11 public health centres throughout Japan. The details of the study design have been described elsewhere ([@bib30]). Study participants responding to the 5-year follow-up questionnaire 1995--1999, aged 45--74 years were included in the present study. One public health centre area was excluded because cancer incidence information was not available. We started with a population-based cohort of 133 323 participants. We excluded 245 disqualified subjects, 11 583 subjects who had died, moved out of the study area or were lost to follow-up before the starting point. From these, 98 505 responded to the questionnaire, (response rate 81.1%). The study received approval from the institutional review board of the National Cancer Center, Tokyo, Japan (No. 13-021).

Dietary assessment
------------------

In the validated FFQ ([@bib14]; [@bib26]; [@bib13]; [@bib25]), participants were asked about the frequency of consumption of individual food items as well as representative sizes relative to standard portions. Details regarding carbohydrate-related food items collected in the JPHC Study were described previously ([@bib25]). Briefly, for rice (japonica rice; round and short grain), participants selected from nine options ranging from \<1 bowl per day to ⩾10 bowls per day and rice-bowl portion size: small (110 g of rice), medium (140 g of rice) and large (170 g of rice).

Follow-up and identification of CRC cases
-----------------------------------------

Subjects were followed for move-out, death and occurrence of cancer from the 5-year follow-up survey (around 1995 and 1998) through 31 December 2008.

We identified CRC incidence by hospital records and population-based cancer registries in the study areas. We coded CRC cases as C18-C20 according to the International Classification of Diseases for Oncology, third edition. We further divided CRC into colon (C18.0--C18.5 for proximal colon and C18.6--C18.7 for distal colon) and rectal (C19 and C20) cancer.

Statistical analysis
--------------------

We excluded participants who had been diagnosed with or reported as having cancer before the starting point (*n*=4086) or subjects with missing information for main exposure variables: that is, rice, bread, noodle intake (*n*=1030) or who reported extreme total energy intakes (upper 2.5% or lower 2.5% *n*=4666) or missing data. A total of 88 722 participants were enrolled in our analysis. Subjects with missing values for covariates were excluded (*n*=15 221), resulting in a final sample of 73 501 men (*n*=34 559) and women (*n*=38 942).

We calculated person-years of follow-up for each participant from the starting point to the date of CRC diagnosis, date of emigration from the study area, date of death or end of the follow-up (31 December 2008), whichever came first. Using Cox proportional hazards models, we calculated the risk for developing CRC and its anatomic subsites for rice, bread, noodle and cereal categories in quartiles and per 100 g increase by sex, with the lowest consumption category as the reference, adjusted for potential confounding variables (indicated in [Tables 2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}). The median value of each quartile was included in the trend analysis. Covariates were included based on associations found in our previous studies on CRC. Dietary factors were adjusted by total energy using the residual method ([@bib16]; [@bib3]; [@bib35]; [@bib1]). All analyses were performed with Stata SE 12.1 (StataCorp, College Station, TX, USA).

Results
=======

During 801 937 person-years of follow-up, we identified 1276 incident cases of CRC (777 for men and 499 for women) ([Table 1](#tbl1){ref-type="table"}). Age-adjusted CRC incidence ranged from 20.62 (highest quarter of rice) to 24.10 (lowest) in men and from 11.20 to 12.05 in women. [Table 2](#tbl2){ref-type="table"} presents Hazard ratios (HRs) and 95% confidence intervals (CIs) for CRC incidence according to quartile of rice, bread, noodle and cereal intake among Japanese men and women. The multivariate HRs for the highest compared with the lowest quartile of rice in men was 0.77 (95% CI, 0.56--1.07). The trend analysis, analysed by scores, was not statistically significant. In women, no association was found for rice intake and CRC risk; however, a non-significant trend between increased cereal intake and the risk of CRC was found.

Further stratified analyses showed site-specific results: colon, rectum, proximal and distal colon cancer ([Table 3](#tbl3){ref-type="table"}). We noted a non-significant inverse association between the quartiles of rice intake and the risk of rectal cancer ([Table 3](#tbl3){ref-type="table"}) in men. In women, a non-significant trend of risk increase by quartile of rice intake and proximal colon cancer ([Table 3](#tbl3){ref-type="table"}) was found but not in men. Distal colon cancer showed no association with rice in both sexes ([Table 3](#tbl3){ref-type="table"}).

A non-significant risk trend was observed for bread, noodle and cereal intake (see [Supplementary Tables](#sup1){ref-type="supplementary-material"}).

Sensitivity analyses were performed excluding cases from the first 3 years of observation; because of the outcome, dietary habits might have been influenced by preclinical symptoms; however, results were not substantially different.

Discussion
==========

This is the first population-based study on the association between rice intake and CRC in Japan. Overall, we found that rice intake was not associated with CRC in men and women. Results were similar for CRC subsites.

The effect of rice on CRC is inconclusive, especially in Asian populations, consuming a diet high in white rice. The Shanghai Women\'s Health Study observed no association between rice intake and the risk of CRC ([@bib18]), which accords with the present result. In the case of Japan, descriptive data regarding the association between rice and CRC are inconsistent. Rice and CRC may be inversely associated as suggested by a decreasing trend of rice intake in Japan in recent decades ([@bib15]) concurrent with increasing trends in CRC incidence. However, a positive link is implied by high mortality rates in prefectures where large amounts of rice are consumed ([@bib29]; [@bib23], [@bib24]). This inconsistency may confuse us to understand the association between rice intake and CRC.

Alternatively, rice intake may be a surrogate of a traditional Japanese diet and thus may represent specific dietary patterns associated with CRC risk. In particular, rice, not specifically white rice, may be an important source of dietary fibre, and a surrogate of starch. Fibre may have a protective role ([@bib33], [@bib32]; [@bib34]); however, results remain elusive. Refined carbohydrates are a possible aetiological factor related to CRC ([@bib5]) through two pathways: deficient fibre or bacterial changes -- degradation of bile salts to carcinogens and induction of tumours ([@bib4]). Starch may be important in the production of short-chain fatty acids and stool quality ([@bib31]), possibly affecting the colon and rectum. Starch may enhance colorectal carcinogenesis via hyperinsulinaemia, assumed to be a mechanism in obesity-related carcinogenesis ([@bib9]). Resistant starch may be protective ([@bib31]).

Some studies indicated that diet-associated risk was more prominent in proximal (right) colon cancer in women ([@bib19], [@bib20], [@bib21]), whereas rectal cancer was more common among men ([@bib36]; [@bib2]). Our non-significant results hint at an inverse trend between rice intake and rectal cancer among men, mirror the findings of a Japanese case--control study in the southern part of the country suggesting that rice consumption is inversely associated with distal colon and rectal cancers ([@bib31]). The difference in risk by sex has also been indicated in previous studies where rice intake was found to be protective regarding risk of colon cancer in men ([@bib36]; [@bib6]). In-depth sex- and CRC subsite-specific research is needed to draw more precise conclusions.

The JPHC Study has several strengths such as including a large general population sample with high response and low loss-to-follow-up rate, and exposure data selection before cancer diagnosis to exclude the recall bias. However, there are several limitations in the present study including some measurement error of long-term dietary intake by our FFQ ([@bib14]), residual confounding effect that we failed to adjust and influence of improvements in CRC diagnostics on CRC incidence ([@bib11]; [@bib7]; [@bib12]; [@bib22]). In addition, we built quartiles of rice that were imbalanced in the number of subjects owing to several big peaks in the distribution.

Despite such limitations, the prospective JPHC Study suggests that the consumption of rice does not have a substantial impact on the risk of CRC in Japanese men and women. Further large prospective studies, especially in the Asian context are needed to confidently interpret these results.
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###### Age-adjusted characteristics of study participants at the 5-year follow-up survey according to quartiles of rice intake in the JPHC Study

                                     **Men (*****n*****=34 559)**   **Women (*****n*****=38 942)**                                                                                                                
  --------------------------------- ------------------------------ -------------------------------- ---------------- ---------------- ---------- -------------- ---------------- ---------------- --------------- ----------
  Rice (*n*)                                     8823                           15 444                    5647             4645                      14 837           5339            15 430           3336            
  Rice (g per day) median (range)            122 (0--136)                   183 (137--183)           244 (190--243)   305 (273--592)   \<0.0001   96 (0--122)    143 (136--144)   183 (147--183)   244(190--487)   \<0.0001
  Rice (g per day)                             92±0.45                         176±0.13                 238±0.14         331±0.65      \<0.0001     90±0.34         140±0.05         183±0.01        263±0.80      \<0.0001
  Age (years)±s.d.                            56.78±7.90                      57.00±7.96               55.16±7.06       55.56±6.92     \<0.0001    55.89±7.69      57.39±7.83       56.80±7.71      55.74±7.10     \<0.0001
  BMI (kg m^−2^)                              23.72±0.03                      23.66±0.02               23.45±0.04       23.42±0.04     \<0.0001    23.37±0.03      23.67±0.04       23.51±0.02      23.40±0.06     \<0.0001
  Alcohol intake (%)                            74.71                           72.18                    70.97            69.83        \<0.0001      22.67           15.88            15.74            15.74       \<0.0001
  Current smoker (%)                            45.71                           45.89                    51.98            50.48        \<0.0001       7.10            4.60             4.57            5.34        \<0.0001
  METs (MET-h per day)                        31.57±0.07                      32.49±0.05               33.68±0.10       34.97±0.11     \<0.0001    31.75±0.05      32.22±0.08       32.27±0.05      32.83±0.10     \<0.0001
  History of type 2 diabetes (%)                10.00                           10.06                     6.97             5.64        \<0.0001       4.36            5.43             3.71            2.86        \<0.0001
  CRC screening (%)                             31.05                           32.64                    32.05            33.78           NS         29.93           33.20            34.54            30.37       \<0.0001
  Post-menopausal status (%)                     ---                             ---                      ---              ---           ---         75.47           75.48            75.31            74.67          NS
  Hormone use (%)                                ---                             ---                      ---              ---           ---          3.08            2.83             2.47            2.20        \<0.0001
  **Dietary intake**                                                                                                                                                                                              
  Total energy (kcal per day)                1945.25±6.45                    2097.09±4.81             2342.33±8.00     2629.27±8.54    \<0.0001   1732.93±4.38    1882.57±7.47     1948.50±4.30    2210.65±9.37    \<0.0001
  Bread (g per day)                            32±0.49                         21±0.27                  20±0.45          16±0.36       \<0.0001     41±0.42         23±0.41          23±0.24          23±0.63      \<0.0001
  Noodles (g per day)                          131±1.40                        117±0.91                 116±1.43         110±1.51      \<0.0001     96±0.81         91±1.17          91±0.69          94±1.53         NS
  Cereals (g per day)                          285±1.59                        326±0.99                 385±1.59         468±1.77      \<0.0001     254±0.96        284±1.36         307±0.79        392±1.94      \<0.0001
  Red meat (g per day)                         49±0.51                         49±0.35                  48±0.56          46±0.60          NS        42±0.33         44±0.57           43±32           41±0.63         NS

Abbreviations: BMI=body mass index; CRC=colorectal cancer; JPHC=Japan Public Health Center-based; MET=metabolic equivalent task; NS=non-significant; PUFA=polyunsaturated fatty acid; Q=quartile.

Values are age-adjusted mean±s.e., unless stated otherwise. Alcohol consumption ⩾1 g ethanol per week; CRC screening included fecal occult blood test, barium enema or colonoscopy; hormone use, current use of exogenous female hormones (%). Subjects with missing data were excluded (BMI: *n*=2195; smoking status: *n*=4122; alcohol consumption: *n*=6698; MET: *n*=2944; menstruation: *n*=2898; hormone use: *n*=2674; *n-*3 PUFA: *n*=98) total excluded: *n*=15 221.

###### Hazard ratio (HR) and 95% CI of colorectal cancer according to quartiles of rice, bread, noodle and cereal intake (g per day) in the JPHC Study

               **Men**    **Women**                                                                                                        
  ------------ --------- ----------- ----- ------------ ------- ------- -------------- ----- ----------- ----- ------------ ------- ------ --------------
  **Rice**                                                                                                                                 
  Q1           122         0--136    217   90 336.74    24.10   1.00    (Reference)    96      0--122    174   161 613.12   12.05   1.00   (Reference)
  Q2           183        137--183   338   161 548.73   21.40   0.88    (0.73--1.06)   143    136--144   71    59 833.11    12.51   1.10   (0.82--1.48)
  Q3           244        190--243   128   62 110.34    22.89   0.91    (0.71--1.18)   183    147--183   216   174 650.78   13.68   1.18   (0.92--1.50)
  Q4           305        273--592   94    52 997.71    20.62   0.77    (0.56--1.07)   244    190--487   38    38 846.61    11.20   1.10   (0.71--1.68)
  *P*-trend                                                     0.179                                                       0.312          
  Per 100 g                                                     0.93    (0.82--1.04)                                                1.11   (0.92--1.35)
  **Bread**                                                                                                                                
  Q1           4            0--4     326   138 252.72   24.76   1.00    (Reference)    4        0--4     155   117 202.34   13.89   1.00   (Reference)
  Q2           13           6--13    194   91 057.57    23.18   1.05    (0.88--1.26)   13       6--13    137   112 631.23   13.76   1.05   (0.83--1.33)
  Q3           19          15--30    114   61 917.40    20.30   0.97    (0.78--1.21)   30      15--45    108   100 095.85   12.45   1.04   (0.80--1.35)
  Q4           60          45--720   143   75 765.81    19.69   0.98    (0.78--1.23)   60      47--720   99    105 014.20   10.68   1.01   (0.75--1.36)
  *P*-trend                                                     0.751                                                       0.986          
  Per 100 g                                                     0.99    (0.78--1.26)                                                1.06   (0.77--1.45)
  **Noodle**                                                                                                                               
  Q1           33           0--45    210   106 032.54   19.98   1.00    (Reference)    24       0--37    129   98 660.89    13.71   1.00   (Reference)
  Q2           68          45--82    170   73 397.31    23.97   1.26    (1.02--1.54)   45      38--68    125   117 114.14   12.09   0.90   (0.70--1.16)
  Q3           114         82--144   203   97 244.08    22.99   1.18    (0.96--1.44)   90      69--114   113   113 433.45   11.54   0.88   (0.67--1.14)
  Q4           224        144--2800  194   90 319.58    23.85   1.18    (0.95--1.47)   173    114--1875  132   105 735.13   14.53   1.12   (0.85--1.47)
  *P*-trend                                                     0.301                                                       0.230          
  Per 100 g                                                     0.99    (0.77--1.26)                                                1.05   (0.77--1.45)
  **Cereal**                                                                                                                               
  Q1           215         30--248   193   86 168.81    22.00   1.00    (Reference)    185     24--128   116   99 398.97    12.37   1.00   (Reference)
  Q2           284        248--318   200   90 071.01    22.90   1.11    (0.90--1.36)   241    218--267   130   108 611.76   13.18   1.15   (0.88--1.49)
  Q3           357        318--406   196   94 350.91    22.62   1.08    (0.87--1.36)   297    267--334   130   112 772.49   13.08   1.19   (0.90--1.58)
  Q4           482        406--2983  188   96 402.78    22.36   1.07    (0.81--1.40)   399    334--2110  123   114 160.40   12.59   1.21   (0.87--1.70)
  *P*-trend                                                     0.780                                                       0.309          
  Per 100 g                                                     0.96    (0.84--1.09)                                                1.08   (0.88--1.32)

Abbreviations: CI=confidence interval; PHC=polyhydrocarbon; Q=quartile.

Multivariate adjusted for age (years, continuous), area (10 PHCs), alcohol consumption (none; drinker: \<150, 150--299, 300--449 or ⩾450 g ethanol per week for men; none; drinker: \<150 or ≥150 g per ethanol per week for women), smoking status (never, past, current: 1--19, 20--29, ⩾30 cigarettes per day), BMI (\<25, 25--26.9, 27--29.9, ⩾30 kg m^−2^), quartile of metabolic equivalent tasks (h per day), history of diabetes mellitus (yes or no) colorectal screening (yes or no), menopausal status (yes or no, women only), use of exogenous female hormones (yes or no, women only), total energy intake (kcal per day, continuous), red meat intake (g per day, quartile) and intakes (according to quartiles) of energy-adjusted calcium (mg per day), magnesium (mg per day), vitamin B6 (mg per day), vitamin B12 (*μ*g per day), folate (*μ*g per day), vitamin D (*μ*g per day), *n*-3 polyunsaturated fatty acids (g per day) and fibre (g per day). Intake of rice, bread and noodles (g per day, quartile) were mutually adjusted for; energy-adjusted cereal intake was analysed in a separate model.

Age-adjusted incidence rate.

###### Hazard ratio (HR) and 95% CI of colon, rectal, proximal and distal colon cancer according to quartiles of rice intake (g per day) in the JPHC Study

              **Men**   **Women**                                                                                                                                                                    
  ----------- --------- ----------- -------------------- ------------------ -------------- ------- -------------------- ------------------ ----- ---------- ----- ------- -------------- ---- ------ --------------
  **Rice**                                                                                                                                                                                           
                                    **Colon**            **Rectum**                                **Colon**            **Rectum**                                                                   
  Q1          122       0--136      140                  1.00               (Reference)    77      1.00                 (Reference)        96    0--122     121   1.00    (Reference)    53   1.00   (Reference)
  Q2          183       137--183    226                  0.93               (0.74--1.17)   112     0.79                 (0.58--1.08)       143   136--144   45    1.02    (0.71--1.46)   26   1.29   (0.78--2.13)
  Q3          244       190--243    87                   1.01               (0.73--1.39)   41      0.76                 (0.49--1.18)       183   147--183   157   1.21    (0.90--1.61)   59   1.12   (0.72--1.77)
  Q4          305       273--592    65                   0.88               (0.58--1.32)   29      0.61                 (0.35--1.07)       244   190--487   33    1.33    (0.82--2.16)   5    0.51   (0.18--1.43)
  *P*-trend                                              0.685                             0.085                                                 0.156            0.726                              
  per 100 g                                              0.98               (0.84--1.14)           0.84                 (0.69--1.03)                              1.16    (0.92--1.46)        1.01   (0.72--1.43)
                                    **Proximal colon**   **Distal colon**                          **Proximal colon**   **Distal colon**                                                             
  Q1          122       0--136      57                   1.00               (Reference)    76      1.00                 (Reference)        96    0--122     66    1.00    (Reference)    42   1.00   (Reference)
  Q2          183       137--183    96                   0.94               (0.66--1.34)   114     0.92                 (0.67--1.26)       143   136--144   24    0.94    (0.57--1.53)   21   1.52   (0.87--2.66)
  Q3          244       190--243    34                   0.88               (0.53--1.45)   49      1.15                 (0.74--1.77)       183   147--183   89    1.18    (0.80--1.73)   61   1.52   (0.94--2.47)
  Q4          305       273--592    36                   1.00               (0.55--1.81)   26      0.77                 (0.42--1.39)       244   190--487   24    1.66    (0.90--3.05)   5    0.68   (0.24--1.95)
  *P*-trend                                              0.903                             0.737                                                 0.139            0.480                              
  per 100 g                                              0.99               (0.79--1.24)           0.95                 (0.77--1.17)                              1.30    (0.96--1.76)        1.07   (0.72--1.57)

Abbreviations: CI=confidence interval; JPHC Study=Japan Public Health Center-based prospective Study; Q=quartile.

Multivariate adjusted for age (years, continuous), area (10 PHCs), alcohol consumption (none; drinker: \<150, 150--299, 300--449 or ⩾450 g ethanol per week for men; none; drinker: \<150 or ⩾150 g per ethanol per week for women), smoking status (never, past, current: 1--19, 20--29, ⩾30 cigarettes per day), BMI (\<25, 25--26.9, 27--29.9, ⩾30 kg m^−2^), quartile of metabolic equivalent tasks (h per day), history of diabetes mellitus (yes or no) colorectal screening (yes or no), menopausal status (yes or no, women only), use of exogenous female hormones (yes or no, women only), total energy intake (kcal per day, continuous), red meat intake (g per day, quartile), bread, noodles (g per day, quartile) and intakes (according quartiles) of energy-adjusted calcium (mg per day), magnesium (mg per day), vitamin B6 (mg per day), vitamin B12 (*μ*g per day), folate (*μ*g per day), vitamin D (*μ*g per day), *n*-3 polyunsaturated fatty acids (g per day) and fibre (g per day). (see [Supplementary Table](#sup1){ref-type="supplementary-material"} for more detail).

[^1]: Study group members are listed in Appendix.
